The effects of virus-specific antibody on the pathogenesis of infection due to herpes simplex virus type 1 (HSV-l) following corneal inoculation of young adult mice were studied. HSV-1 was inoculated onto the corneal surface immediately after trephination with a capillary pipette. After inoculation, virus spread to the trigeminal ganglion and brain within two days and caused acute herpetic encephalitis, which killed infected ani-mals eight to 10 days after infection. Rabbit hyperimmune antisera to HSV-1 were pre-pared, diluted to contain antibody at a titer of 1:150, and administered intraperitoneally to mice 8 hr after corneal infection. Administration of antisera did not interfere with the spread of HSV-l from the site of infection to the...
AbstractRabbits latently infected with herpes simplex virus type 1 (HSV-1) were vaccinated either pe...
Antiviral effects of a DNA vaccine against herpes simplex virus 1 (HSV-1) glycoprotein D (gD) were e...
Antiviral effects of a DNA vaccine against herpes simplex virus 1 (HSV-1) glycoprotein D (gD) were e...
The effectiveness of passively transferred antibodies directed against the secretory form of herpes ...
Replication-defective mutants of herpes simplex virus 1 (HSV-1) elicit immune responses in mice that...
Herpes simplex virus (HSV) is a leading cause of blindness and viral encephalitis in the developed w...
The increasing incidence of acyclovir (ACV) and multidrug-resistant strains in patients with corneal...
PurposeBlinding ocular herpetic disease in humans is due to spontaneous reactivation of herpes simpl...
Two different procedures for inoculation of HSV on corneas of BALB/c mice were evaluated. The first ...
AbstractImmunization with heat-inactivated herpes simplex virus type 1 (HSV-1) 2–5 days before ocula...
AbstractReplication-defective mutants of herpes simplex virus 1 (HSV-1) elicit immune responses in m...
AbstractReplication-defective mutants of herpes simplex virus 1 (HSV-1) elicit immune responses in m...
The role of antiviral antibody in controlling the acute and latent phases of herpes implex virus (HS...
The role of cellular immunity, humoral antibody, and interferon in recovery from pri-mary systemic i...
The efficacy of different therapies and vaccine preparations was assessed for treating or preventing...
AbstractRabbits latently infected with herpes simplex virus type 1 (HSV-1) were vaccinated either pe...
Antiviral effects of a DNA vaccine against herpes simplex virus 1 (HSV-1) glycoprotein D (gD) were e...
Antiviral effects of a DNA vaccine against herpes simplex virus 1 (HSV-1) glycoprotein D (gD) were e...
The effectiveness of passively transferred antibodies directed against the secretory form of herpes ...
Replication-defective mutants of herpes simplex virus 1 (HSV-1) elicit immune responses in mice that...
Herpes simplex virus (HSV) is a leading cause of blindness and viral encephalitis in the developed w...
The increasing incidence of acyclovir (ACV) and multidrug-resistant strains in patients with corneal...
PurposeBlinding ocular herpetic disease in humans is due to spontaneous reactivation of herpes simpl...
Two different procedures for inoculation of HSV on corneas of BALB/c mice were evaluated. The first ...
AbstractImmunization with heat-inactivated herpes simplex virus type 1 (HSV-1) 2–5 days before ocula...
AbstractReplication-defective mutants of herpes simplex virus 1 (HSV-1) elicit immune responses in m...
AbstractReplication-defective mutants of herpes simplex virus 1 (HSV-1) elicit immune responses in m...
The role of antiviral antibody in controlling the acute and latent phases of herpes implex virus (HS...
The role of cellular immunity, humoral antibody, and interferon in recovery from pri-mary systemic i...
The efficacy of different therapies and vaccine preparations was assessed for treating or preventing...
AbstractRabbits latently infected with herpes simplex virus type 1 (HSV-1) were vaccinated either pe...
Antiviral effects of a DNA vaccine against herpes simplex virus 1 (HSV-1) glycoprotein D (gD) were e...
Antiviral effects of a DNA vaccine against herpes simplex virus 1 (HSV-1) glycoprotein D (gD) were e...